Hormone receptors (estrogen receptor [ER] and progesterone receptor [PR]) and human epidermal growth factor receptor 2 [HER2] status in primary breast cancers (BC) not only provides prognostic information but it is also crucial for deciding on an effective treatment plan. This evidence concerns the gene NR4A1 and breast cancer.